Consistent with our previous results5, biweekly recombinant mouse IL-22 (rmIL-22) treatment in the high-fat diet-induced obesity murine model induced a reduction in body weight which was accompanied by improved glucose tolerance (Supplementary Fig. 1a–c). The gene discussed is IL22; the disease is obesity due to melanocortin 4 receptor deficiency.